Medication therapy management services

Research output: Chapter in Book/Report/Conference proceedingChapter


Introduction The ineffective and unfortunate consequences of medication use, referred to as drug-related morbidity and mortality (DRM&M), are an insidious public health nemesis that has persisted for many years. It’s almost as if consumers perceive the unfortunate consequences of medication use as inevitable and a typical cost of doing business. The magnitude of this problem came to light with a study published in 1995 [1]. Additional research and analyses followed indicating that DRM&M is a nearly $(USD)300 billion annual burden in the United States [2-4]. In other words, we spend almost as much to fix the bad things that happen when patients take medications as we do to purchase pharmaceutical products.

Original languageEnglish (US)
Title of host publicationPharmaceutical Public Policy
PublisherTaylor and Francis
Number of pages10
ISBN (Electronic)9781498748513
ISBN (Print)9781498748506
StatePublished - Jan 1 2016


Dive into the research topics of 'Medication therapy management services'. Together they form a unique fingerprint.

Cite this